Financhill
Buy
75

CADL Quote, Financials, Valuation and Earnings

Last price:
$6.02
Seasonality move :
2.55%
Day range:
$5.90 - $6.07
52-week range:
$4.25 - $13.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1,949.18x
P/B ratio:
4.12x
Volume:
304.4K
Avg. volume:
916.7K
1-year change:
-34.46%
Market cap:
$329.9M
Revenue:
--
EPS (TTM):
-$0.56

Earnings Data

Next earnings date for CADL
Mar 12
2026
Most recent earnings per share
-$0.21
Missed by $0.04
(Nov 13/2025)
Consensus Estimate
-$0.17
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CADL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/12/2026 Q4 -- -- -- -$0.24 --
11/13/2025 Q3 -- -- -$0.21 -$0.17 -$0.04
08/14/2025 Q2 -- -- -$0.09 -$0.18 $0.08
05/15/2025 Q1 -- -- $0.13 -$0.24 $0.37
03/13/2025 Q4 -- -- -$0.40 -$0.23 -$0.17
11/14/2024 Q3 -- -- -$0.33 -- --
08/13/2024 Q2 -- -- -$0.74 -- --
05/14/2024 Q1 -- -- -$0.28 -- --
03/28/2024 Q4 -- -- -$0.38 -- --
11/09/2023 Q3 -- -- -$0.29 -- --
08/10/2023 Q2 -- -- -$0.33 -$0.37 $0.04
05/11/2023 Q1 -- -- -$0.30 -- --
03/30/2023 Q4 -- $31K -$0.18 -- --
11/10/2022 Q3 -- $31K -$0.30 -- --
08/05/2022 Q2 -- $31K -$0.14 -- --
05/12/2022 Q1 -- $31K -$0.03 -- --
03/29/2022 Q4 -- $31K $0.05 -- --
11/12/2021 Q3 -- $31K -$0.56 -- --
09/08/2021 Q2 -- $31K -$0.60 -- --
03/31/2021 Q1 -- $31K -$0.15 -- --
12/31/2020 Q4 -- $31K -$0.56 -- --
09/30/2020 Q3 -- $31K -$0.09 -- --
06/30/2020 Q2 -- $31K -$0.15 -- --
03/31/2020 Q1 -- $31K -$0.06 -- --

Candel Therapeutics, Inc. Earnings Questions

  • How Much did Candel Therapeutics, Inc. Generate in Revenue Last Quarter?

    Candel Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Candel Therapeutics, Inc. Beat Earnings Last Quarter?

    Candel Therapeutics, Inc. announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.17 per share.

  • Is Candel Therapeutics, Inc. Profitable?

    Candel Therapeutics, Inc. reported -$195K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Candel Therapeutics, Inc. EPS Next Year?

    Candel Therapeutics, Inc.'s earnings are forecast to decrease from -$1.74 per share to -$0.61 per share next year representing a decrease of -65.27%.

  • When is Candel Therapeutics, Inc.'s Earnings Date?

    Candel Therapeutics, Inc.'s next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
72
GLTO alert for Dec 27

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Sell
20
SMX alert for Dec 27

SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.

Sell
11
CDNAF alert for Dec 27

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock